An alternative explanation of hypertension associated with 17α-hydroxylase deficiency syndrome

Steroids

Volumn 79, Issue , 2014, Pages 44-48

  Morris, David J ^a   Latif, Syed A ^a   Brem, Andrew S ^b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

11 OH (allo) 5 preganolone; 17 Hydroxylase deficiency; 3 ,5 Tetrahydro corticosterone; Intestinal flora; Kidney 11 HSD2 GALFs

Indexed keywords

11 BETA OH (ALLO) 5 ALPHA PREGANOLONE; 11BETA HYDROXYPROGESTERONE; 11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; 3 ALPHA, 5 ALPHA TETRAHYDRO 11 BETA HYDROXY PROGESTERONE; 3 ALPHA, 5 ALPHA TETRAHYDRO 11 KETO PROGESTERONE; 3 ALPHA, 5 ALPHA TETRAHYDRO CORTICOSTERONE; CORTICOSTERONE; CORTICOSTERONE DERIVATIVE; CORTICOTROPIN; DEOXYCORTICOSTERONE; DRUG METABOLITE; GLYCYRRHETINIC ACID; HYDROCORTISONE; NEOMYCIN; PROGESTERONE DERIVATIVE; STEROID; STEROID 17ALPHA MONOOXYGENASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANAEROBIC BACTERIUM; ARTICLE; BACTERIUM TRANSFORMATION; BLOOD VESSEL REACTIVITY; DISEASE ASSOCIATION; DISORDERS OF STEROID METABOLISM; ENDOTHELIUM CELL; ENTEROHEPATIC CIRCULATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; IC 50; INTESTINE FLORA; KIDNEY PROXIMAL TUBULE; LEYDIG CELL; LIVER METABOLISM; METABOLITE; NONHUMAN; OXIDATION; PLASMA RENIN ACTIVITY; STEROID 17ALPHA MONOOXYGENASE DEFICIENCY SYNDROME; STEROID METABOLISM; STEROID URINE LEVEL; URINARY EXCRETION; VASCULAR SMOOTH MUSCLE; VASCULAR TISSUE;

RATTUS;

11Β-OH-(ALLO)-5Α-PREGANOLONE; 17Α-HYDROXYLASE DEFICIENCY; 3Α,5Α-TETRAHYDRO-CORTICOSTERONE; INTESTINAL FLORA; KIDNEY 11Β-HSD2-GALFS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; CORTICOSTERONE; DESOXYCORTICOSTERONE; ENZYME INHIBITORS; HUMANS; HYDROCORTISONE; HYPERTENSION; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; PROGESTERONE; RATS; SODIUM; STEROID 17-ALPHA-HYDROXYLASE; SYNDROME;

EID: 84888221465     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2013.10.006     Document Type: Review

References (40)

1. E.G. Biglieri, M.A. Herron, and N. Brust 17-Hydroxylation deficiency in man J Clin Invest 45 1966 1946 1954
2. E.G. Biglieri, and F. Mantero The characteristics, course, and implication of the 17-hydroxylation deficiency in man M. Finkelstein, Research in steroids, V 1977 Societa Editrice Universo Roma 385 399
3. M.I. New Male pseudohermaphroditism due to 17α-hydroxylase deficiency J Clin Invest 49 1970 1930 1941
4. O. Goldsmith, D.H. Solomon, and R. Horton Hypogonadism and mineralocotticoid excess. The 17α-hydroxylase deficiency syndrome NEJM 277 1967 673 677
5. E. Rusvai, and A. Naray-Fejes-Toth A new isoform of 11β- hydroxysteroid dehydrogenase in aldosterone target cells J Biol Chem 268 1993 10717 10720 (Pubitemid 23162245)
6. S.A. Latif, M.F. Sheff, C.E. Ribeiro, and D.J. Morris 11β-Hydroxysteroid dehydrogenase (11β-HSD) isoform 2 from sheep kidney is selectively inhibited by 5α-metabolites (but not 5β-metabolites) of adrenal cortex Steroids 62 1997 230 237
7. P.M. Stewart, A.M. Wallace, R. Valentino, D. Burt, C.H.L. Shackleton, and C.R.W. Edwards Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age Lancet 2 1987 821 824
8. P.C. White, Mune Testo, and A.K. Agarwal 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess Endocrin Rev 18 1997 135 156 (Pubitemid 27076458)
9. M.I. New, M.P. Seaman, and R.E. Peterson A method for the simultaneous determination of the secretion rates of cortisol, 11-desoxycortisol, corticosterone, 11-desoxycorticosterone and aldosterone J Clin Endocrinol 29 1969 514 522
10. V.D. Bokkenhauser, J.B. Suzuki, S.B. Polovsky, J. Winter, and W.G. Kelley Metabolism of deoxycorticosterone by human fecal flora Appl Microbiol 30 1975 82 90
11. C.H.L. Shackleton, E.G. Biglieri, E. Roitman, and J. Honour Metabolism of radiolabeled corticosterone in an adult with the 17α-hydroxylase deficiency syndrome J Clin Endocrinol Metab 48 1979 976 982 (Pubitemid 9190850)
12. J.H. Honour, J. Tourniaire, E.G. Biglieri, and C.H.L. Shackleton Urinary steroid excretion in 17α-hydroxylase deficiency J Steroid Biochem 9 1977 495 505
13. H. Eriksson, J.-A. Gustafsson, and J. Sjovall Steroids in germfree and conventional rats. 21-Dehydroxylation by intestinal microorganisms Eur J Biochem 9 1969 550 554
14. V.D. Bokkenhauser, J. Winter, P. Dehazya, and W.G. Kelly Isolation and characterization of human fecal bacteria capable of 21-dehydroxylating corticoids Appl Environ Microbiol 34 1977 571 585
15. S.D. Feighner, and P.B. Hylemon Characterization of a corticosteroid 21-dehydroxylase from the intestinal bacterium, Eubacterium lentum J Lipid Res 21 1980 585 593 (Pubitemid 11194853)
16. J. Honour The possible involvement of intestinal bacteria in steroidal hypertension Endocrinology 110 1982 285 287 (Pubitemid 12198210)
17. J. Honour, S.P. Borriello, U. Ganten, and P. Honour Antibiotics attenuate experimental hypertension in rats J Endocrinol 105 1985 347 350 (Pubitemid 15045850)
18. D. Fraillon, K.N. Wynne, and J.W. Funder Further studies on neomycin and experimental hypertension Clin Exp Pharmacol Physiol 11 1984 339 342
19. +-dependant isoform of 11β-hydroxysteroid dehydrogenase Endocinology 131 1992 970 972
20. C. Monder, and P.C. White 11β-Hydroxysteroid dehydrogenase Vitam Horm 47 1993 187 269
21. D.J. Morris, A.S. Brem, R. Ge, P.H. Jellinck, R.R. Sakai, and M.P. Hardy At the cutting edge. The functional roles of 11β-HSD1: vascular tissue, testis and brain Mol Cell Endocrinol 203 2003 1 12 (Pubitemid 36627583)
22. R. Gong, D.J. Morris, and A.S. Brem 11β-Hydroxysteroid dehydrogenase (11β-HSD1 and 11β-HSD2) in human kidney: 11β-HSD1 co-localizes with COX-2 Life Sci 82 2008 631 637
23. + on glycyrrhetinic acid-like factors (kidney-11β-HSD2 GALFs) in human essential hypertension Hypertension 31 1998 469 472
24. S.A. Latif, H.A. Pardo, M.P. Hardy, and D.J. Morris Endogenous selective inhibitors of 11β-OH-steroid dehydrogenase isoforms 1 and 2 of adrenal origin Mol Cell Endocrinol 243 2005 43 50 (Pubitemid 41572277)
25. D.J. Morris, S.A. Latif, M.P. Hardy, and A.S. Brem Endogenous inhibitors (GALFs) of 11β-OH-Steroid dehydrogenase isoforms 1 and 2; derivatives of adrenally produced corticosterone and cortisol J Steroid Biochem Mol Biol 104 2007 161 168 (Pubitemid 46891822)
26. A.S. Brem, R.B. Bina, T.C. King, and D.J. Morris Localization of two 11β-OH steroid dehydrogenase isoforms in aortic endothelial cells Hypertension 31 1998 583 585
27. G.W. Souness, and D.J. Morris 11α- and 11β- hydroxyprogesterone, potent inhibitors of 11β-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat Hypertension 27 1996 421 425 (Pubitemid 26082083)
28. T.-Q. Cai, B. Wong, S.S. Mundt, R. Thieringer, S.D. Wright, and A. Herman-Vosatka Induction of 11β-hydroxysteroid dehydrogenase type 1 but not type-2 in human aortic smooth muscle cells by inflammatory stimuli J Steroid Biochem Mol Biol 77 2001 117 122 (Pubitemid 32476819)
29. M.E. Ullian, and L.G. Walsh Corticosterone metabolism and effects on angiotensin II receptors in vascular smooth muscle Circ Res 77 1995 702 709
30. C. Christy, P.W.F. Hadoke, J.M. Paterson, J.J. Mullins, J.R. Seckl, and B.R. Walker 11β-hydroxysteroid dehydrogenase type 2 in mouse aorta. Localization and influence on response to glucocorticoids Hypertension 42 2003 580 587 (Pubitemid 37237357)
31. D.J. Morris, S.A. Latif, Y.H. Lo, W.R. Lichtfield, and G.W. Williams Correlation of levels of glycyrrhetinic acid-like factors (kidney-11β-HSD2 GALFs) with urinary free cortisol and plasma renin levels in human essential hypertension J Am Soc Hypertension 2 2008 286 293
32. S.R. Mallin Congenital adrenal hyperplasia secondary to 17-hydroxylase deficiency: two sisters with amenorrhea, hypokalemia, hypertension, and cystic ovaries Ann Intern Med 70 1969 69 75
33. Y.H. Lo, M.F. Sheff, S.A. Latif, C. Ribeiro, H. Silver, and D.J. Morris Kidney 11β-HSD2 is inhibited by glycyrrhetinic acid-like factors (GALFs) in human urine Hypertension 29 1997 500 505 (Pubitemid 27074090)
34. T.E. Chapman, G.P.B. Kraan, G.T. Nagel, B.G. Wolthers, and N.M. Drayer Measurement of the cortisol production rate in two sisters with 17-hydroxylase deficiency using [1,2,3,4-13C] cortisol and isotope dilution mass spectrometry J Steroid Biochem 38 1991 489 496
35. B.P. Lisboa, J.M. Halket, I. Ganschow, and C. Ruiz-Gonzalez Steroid excretion in a case of 17-hydroxylase deficiency investigated by computerized gas chromatography-mass spectrometry Acta Med Port 1 1979 433 449 (Pubitemid 10198161)
36. G.W. Souness, A.S. Brem, and D.J. Morris 11β-Hydroxysteroid dehydrogenase antisense affects vascular contactile response and glucocorticoid metabolism Steroids 67 2002 195 201 (Pubitemid 34150139)
37. L. Kornel, W.R. Starnes, S.R. Holl, and A. Hill Studies on steroid conjugates. Part VI. Quantitative paper chromatography of urinary corticosteroids in essential hypertension J Clin Endocrinol Metab 29 1969 1608 1617
38. A. Soro, M.C. Ingram, G. Tonolo, N. Glorioso, and R. Fraser Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in subjects with untreated essential hypertension Hypertension 25 1995 67 70
39. B.R. Walker, P.M. Stewart, C.H.R. Shackleton, P.L. Padfield, and C.R.W. Edwards Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension Clin Endocrinol 39 1993 221 227 (Pubitemid 23224295)
40. J.W. Conn, S.S. Fajans, and L.H. Louis Metabolic effect in man of orally and parenterally administered corticosterone (Compound B) Trans Assoc Amer Phys 64 1951 269 278